Great controversy erupted after the report of the EXCEL trial of percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG) in patients with left main disease. I discussed it in this space in a piece I called, “What's Right about Left Main?” Much of that controversy was over the definition of periprocedural myocardial infarction (MI) used as a part of the composite endpoint of the trial.
Author bio
Cardiovascular Revascularization Medicine, 2021-01-01, Volume 22, Pages 124-125, Copyright © 2020 Elsevier Inc.
Source:
Read the full article on Science Direct: Periprocedural MI Should Not Be an Endpoint